These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30980157)

  • 1. [Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)].
    Wascher TC; Paulweber B; Toplak H; Saely CH; Drexel H; Föger B; Hoppichler F; Stulnig T; Stingl H; Clodi M;
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):136-138. PubMed ID: 30980157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipids--Diagnosis and therapy in diabetes mellitus].
    Wascher TC; Paulweber B; Toplak H; Säly CH; Drexel H; Föger B; Hoppichler F
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S68-70. PubMed ID: 27052223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)].
    Wascher TC; Paulweber B; Toplak H; Saely CH; Drexel H; Föger B; Hoppichler F; Stulnig T; Stingl H; Clodi M;
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):157-160. PubMed ID: 37101037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipids: diagnosis and therapy in type 2 diabetes].
    Wascher TC; Paulweber B; Toplak H; Saely C; Drexel H
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():28-30. PubMed ID: 23250461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia.
    Dake AW; Sora ND
    Am J Med Sci; 2016 Apr; 351(4):361-5. PubMed ID: 27079341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
    Pérez A
    Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585
    [No Abstract]   [Full Text] [Related]  

  • 8. Role for combination therapy in diabetic dyslipidemia.
    Warraich HJ; Wong ND; Rana JS
    Curr Cardiol Rep; 2015 May; 17(5):32. PubMed ID: 25894802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy of diabetic dyslipidemia: do the statins suffice?
    Mooradian AD
    Am J Ther; 2015; 22(1):87-8. PubMed ID: 23728161
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid management--treatment goal and strategy].
    Koshiyama H
    Nihon Rinsho; 2006 Nov; 64(11):2102-6. PubMed ID: 17087303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetes.
    Karalis DG
    Clin Cardiol; 2008 Jun; 31(6):241-8. PubMed ID: 17847038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids: new guidelines, intensive treatment, and future directions.
    Jones PH
    Tex Heart Inst J; 2006; 33(2):180-3. PubMed ID: 16878620
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins?
    Zoungas S; Curtis AJ; McNeil JJ; Tonkin AM
    Clin Pharmacol Ther; 2014 Aug; 96(2):192-205. PubMed ID: 24727468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of diabetic dyslipidemia: need for reappraisal of the goals.
    Khera A; McGuire DK
    Am J Cardiovasc Drugs; 2005; 5(2):83-91. PubMed ID: 15725039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New European and American guidelines on the management of blood cholesterol : similarities and differences].
    Butty A; Rodondi N; Nanchen D
    Rev Med Suisse; 2020 Mar; 16(684):438-443. PubMed ID: 32134222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].
    Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR
    Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic Dyslipidemia].
    Merkel M
    Dtsch Med Wochenschr; 2021 Jan; 146(2):85-91. PubMed ID: 33465804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of dyslipidemia in diabetes.
    Solano MP; Goldberg RB
    Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.